ANIK
Anika Therapeutics Inc
NASDAQ: ANIK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.55
+0.94% today
Updated 2026-10-28
Market cap
$270.60M
P/E ratio
—
P/S ratio
2.24x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$9 – $23
Volume
0.1M
Anika Therapeutics Inc (ANIK) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.55
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$32.56
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -3.14%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.